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Abstract 
 Drotaverine is considered as an inhibitor of cyclic-3′,5′-nucleotide-phophodiesterase 
(PDE) enzymes. However, published receptor binding data supports the potential L-
type Voltage Operated Calcium Channel (L-VOCC) blocking effect of drotaverine too. 
Hence, in this work we are focusing on the potential L-VOCC blocking effect of 
drotaverine using L-VOCC associated functional in vitro models. Accordingly, 
drotaverine and reference agents were tested on KCl-induced guinea pig tracheal 
contraction. It was found that drotaverine, like the L-VOCC blockers nifedipine or 
diltiazem, inhibited the KCl-induced inward Ca2+- induced contraction in a 
concentration dependent fashion. The PDE-inhibitor theophylline had no effect on the 
KCl-evoked contractions indicating its lack of inhibition on inward Ca2+ flow. 
Drotaverine was also tested on the L-VOCC mediated resting Ca2+ refill model. In this 
model the extracellular Ca2+ enters  the cells to replenish the emptied intracellular 
Ca2+ stores. Drotaverine and L-VOCC blocker reference molecules inhibited the Ca2+ 
replenishment of Ca2+ depleted preparations detected by agonist-induced 
contractions in post Ca2+ replenishment Ca2+ free medium. Theophylline didn’t modify 
the Ca2+ store replenishment following contraction. It seems that drotaverine but not 
theophylline inhibit the inward Ca2+ flux. Addition of CaCl2 to Ca2+ free medium 
containing the agonist, induced inward Ca2+ flow and subsequent contraction of Ca2+ 
depleted tracheal preparations. Drotaverine similar to the L-VOCC blockers, inhibited 
inward Ca2+ flow and blunted the slope of CaCl2-induced contraction in agonist 
containing Ca2+ free medium withCa2+ depleted tracheal preparations. These results 
show that drotaverine behaves like L-VOCC blockers but unlike PDE inhibitors using 
L-VOCC associated in vitro experimental models. 
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Introduction 
   Two families of drugs which inhibit PDE activity, methylxanthines and isoquinolines, 
are used clinically in 2 distinct therapeutic areas involving smooth muscle function.  
Methylxanthines, such as theophylline, are frontline asthma medications, while the 
isoquinolines, like papaverine, are used to ameliorate the symptoms of visceral 
smooth muscle spasm and associated pain.  However, neither of them are active if 
used in the opposite field – why is that?  Based on indirect experimental evidence the 
difference may be associated with their differing activity on the voltage operated 
calcium channel (L-VOCC). 
The natural isoquinoline alkaloide of Papaver sumniferrum, papaverine and its 
synthetic derivate drotaverine have been broadly used as antispasmodic agents in 
human medicine for decades. It has been published that drotaverine binds to the L-
VOCC on pregnant rat uterine membranes (Tömösközi et al., 2002) while Ca2+ 
activated potassium channels and L-VOCCs may be involved in papaverine-induced 
vascular relaxation in rat basilar artery (Han et al., 2007). Moreover, it was shown 
that both molecules inhibit cyclic-3′,5′-nucleotide-phophodiesterase (PDE) enzymes 
with concentration dependent specificity (Kukovetz and Pöch,1970; Triner et 
al.,1970; Pöch and Kukovetz, 1971; Kukovetz et al., 1976, Ji-Qun et al., 1995). 
However, the detailed molecular mechanism of action and associated function of 
drotaverine on airway smooth muscle has not yet been systematically investigated. 
Especially, the interaction of drotaverine with the Ca2+ flux essential for the 
contraction-relaxation machinery of airway smooth muscle has not been tested. Both 
of these cellular mechanisms play a fundamental regulatory role in smooth muscle 
function. In airway smooth muscle, bronchodilatory agents increase the intracellular 
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cAMP level (e.g. by the inhibition of the PDEs) and cause the relaxation of 
precontracted (post-agonist administration) preparations (Torphy and Undem, 1991; 
Frossard et al., 1981). However, these agents are less effective in the inhibition of the 
agonist-induced contraction (pre-agonist administration) (Bilcíková et al., 1987). The 
airway smooth muscle contractile mechanism is considered to be triggered either by 
release of intracellularly sequestered Ca2+ or by the increased influx of extracellular 
Ca2+. In airway smooth muscle the Ca2+ release from the intracellular stores 
predominates over inward Ca2+ flux through L-VOCCs after receptor activation-
induced airway smooth muscle contraction (Pelaia G et al., 2008). While operation of 
L-VOCCs can induce some relaxation of agonist-induced pre-contracted airway 
smooth muscle (Fanta et al., 1982) they are not effective prior to agonist 
administration (Foster et al., 1984).  This may explain why L-VOCC blockers have no 
principal therapeutic benefit for the treatment of bronchial asthma (Hirota et al., 
2003).  Airway smooth muscle receptor mediated activation uses intracelleluar Ca2+ 
stores, whereas vascular smooth muscle is more dependant on Ca2+ influx.  
However, the L-VOCCs may play a role in the Ca2+ balance necessary for the 
maintenance of the physiological airway smooth muscle function. In this context the 
principal role of L-VOCCs may be the regulation of the Ca2+ influx responsible for 
refilling of the intracellular Ca2+ stores that are partly depleted during agonist-induced 
contraction in airway smooth muscle (Bourreau et al., 1993). It has been 
demonstrated that L-VOCC blockers are able to inhibit the refill of the depleted 
sarcoplasmatic Ca2+ stores in resting conditions (Bourreau et al., 1991; Liu and 
Farley, 1996), while their impact on receptor activation associated inward Ca2+ 
currents and subsequent contractions in normal Ca2+ containing medium is minimal 
(Cheng and Townley, 1983). We have hypothesized that the L-VOCCs may also play 
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an important role in receptor mediated inward Ca2+ current associated contractions 
when  Ca2+ depleted preparations in Ca2+ free medium were supplemented with 
extracellular Ca2+. Our aim with this study was to generate functional data supporting 
the potential L-VOCC blocking effect of drotaverine using proven L-VOCC dependent 
tracheal models (e.g. KCl depolarisation induced contractions (Foster et al., 1983), 
resting Ca2+-refill linked contractions and receptor mediatedinward Ca2+-induced 
contractions). 
Methods 
Chemicals 
     The ingredients of the Krebs-Henseleit solution: KCl, CaCl2.2H2O, KH2PO4, 
NaHCO3, MgSO4.7H2O were obtained from Merck Inc (Darmstadt, Germany). NaCl 
from Reanal ZRt. Budapest, Hungary.The drotaverine HCl was synthesized in 
Chinoin Co.Ltd., Budapest, Hungary; EGTA, indomethacin, nifedipine, theophylline, 
papaverine HCl, diltiazem HCl, Acetyl-β-methylcholine chloride (methacholine), 
histamine dihydrochloride, D-(+)-glucose were purchased from Sigma (St Louis, MO).  
Animals 
     Male guinea pigs 300-350 g bodyweight (Harlan MD, distributed by INNOVO Ltd., 
Gödöllő, Hungary) were used. All experiments were performed in accordance with 
the Institutional Ethical Codex, Hungarian Act of Animal Care and Experimentation 
(1998, XXVIII, section 243/1998) and the European Union guidelines (directive 
2010/63/EU). The animals were housed in open cages in a temperature-controlled 
and ventilated environment (21-23°C) with a 12-hour light-dark cycle. Water and 
standard ascorbic acid containing guinea pig chow (Altromin) were provided ad 
libitum. The animals were tissue donors therefore, the approval of the experimental 
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protocol by the Hungarian Governmental Animal Ethics Committee (ÁTET) was not 
mandatory. 
Isolation of the trachea, and organ bath preparation 
     On the day of the experiments the guinea-pigs were euthanized by an overdose of 
pentobarbital sodium. The trachea was rapidly removed and placed in Krebs-
Henseleit (KH) solution of the following composition (mM): NaCl-119, NaHCO3-25.0, 
CaCl2-2.5, KCl-4.7, KH2PO4-1.2, MgSO4-1.2, glucose-11.1, 5·10-6 M indomethacin. 
The cartilaginous rings from the distal part of the trachea were opened longitudinally 
and mounted in a 20 ml organ bath containing KH solution, maintained at 37.4oC, 
and continuously bubbled with 95 % O2 and 5 % CO2 to give a pH of 7.4 ± 0.1. The 
preparations were preloaded with 5 millinewton (mN; approx. 0.5 g). The tissues 
were then  allowed to equilibrate for at least 1 hour, during which time they were 
washed approximately every 20 min with fresh KH solution. Eight tracheal strip 
preparations were used from the same guinea pigs on the same day. Four 
preparations were used for the control groups while the other four preparations were 
used for the test compounds. Earlier studies showed no difference in reactivity to 
histamine or methacholine with respect to tracheal ring location from this part of the 
trachea (data not shown).     The strength of the isometric contractile responses was 
measured (mN) using a force displacement transducer and preamplifier (MDE Co. 
Ltd., Budapest, Hungary). The experimental data were collected and evaluated by a 
computer aided data acquisition system (SpelIso v3.2 software; MDE Co. Ltd., 
Budapest, Hungary). 
Due to small variations in the baselines and the acclimation of the tissue preparations 
to the organ bath environment, the second contraction force was in many cases 
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higher than the first (but not as high as the third contraction force). Consequently the 
second contraction was used as the control in all the experimental protocols.  
KCl induced contraction protocol 
     Contractions of the 8 mounted tracheal preparations in normal KH solution were 
evoked by consecutive applications of 20, 30 and 50 mM KCl, separated by a wash 
out Figure 1A). The contraction force was continuously registered. The contraction 
force derived from the second concentration-response curve was used as the control 
value (100% contraction). Once the control value had been established, 4 of the 8 
preparations were treated with10-7 M of the test moleculeswhile the other 4 were 
treated with the vehicle of the test molecule (control preparations). Following 15 min 
incubation, another concentration-response curve to KCl was constructed for all 8 
preparations. After a wash out, the experiment was repeated using 10-6 M (or vehicle) 
and 10-5 M (or vehicle) test molecule, with a wash out between increasing doses of 
test molecule. The experimental design is shown in Figure 1A.  The percentage 
inhibition was calculated for each dose of the test molecule at every KCl 
concentration. The test molecule dose causing a 50 % inhibition of KCl contraction 
was calculated in each case, when feasible.  
Ca2+ reload following agonist-induced contractions in Ca2+ free medium 
(resting refill) 
     The intracellular Ca2+ dependent contractions were tested using two mediators 
that induce contraction of airway smooth muscle, histamine (3x10-6 M) and 
methacholine (5x10-7 M). The concentrations chosen were the calculated EC50 values 
for these mediators from previous experiments in our laboratory (data not shown). 
Histamine and methacholine were used in separate experiments. Following the 
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equilibration period two consecutive contractions were evoked with either histamine 
or methacholine separated by a wash out. The second contraction was considered 
the control (100%) contraction. After washing out the agonist, 2.5 mM Ca2+ 
containing KH solution was changed to a Ca2+ free medium. Next, 3 consecutive 
contractions were evoked by the constrictor agents each separated by a wash out in 
order to deplete the sarcoplasmatic Ca2+ stores. The third agonist stimulation usually 
evoked a minimal, if any, contraction indicating depletion of the intracellular calcium 
stores (Table 2A, B, 5th contraction column). Following the last wash out in Ca2+ free 
medium, test compounds (10-5 M) were added to 4 of the 8 organ baths. The other 4 
preparations served as controls with only the vehicle added to the baths. After a 15 
min incubation the solution in the bath was changed to normal KH solution (2.5 mM 
Ca2+) containing 10-5 M test molecule (or vehicle). The preparations were then 
incubated for 30 min without any agonist stimulation. Previous studies have shown 
this was sufficient time for the Ca2+ refill of intracellular calcium stores. The normal 
KH solution was then changed to the Ca2+ free KH solution in all eight organ baths, 
after which three consecutive contractions were evoked by constrictor agonists, each 
separated by a wash out period. The contraction force was measured (mN) and the 
percentage contraction values were calculated using the second agonist-induced 
contraction as 100 % contraction. The experimental design is shown in Figure 1B. 
CaCl2-induced contraction in agonist containing Ca2+ free medium (receptor 
operated refill) 
     The experimental protocol was indentical with the “resting refill” protocol up to the 
intracellular Ca2+ depletion step in Ca2+ free medium. As before, the third agonist 
stimulation evoked only limited if any contraction denoting the depleted Ca2+ content 
of the intracellular calcium stores (Table 2A, B 5th contraction column). At this point, 
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10-5 M of test molecule was added to 4 of the organ baths while the other 4 
preparations were treated with the vehicle as control preparations. After 15 min 
incubation, 2.75 mM CaCl2 was added to all 8 organ baths. The experimental design 
is presented in Figure 1C. In this experimental protocol both the maximum 
contraction and the slope of the contractions were evaluated. The percentage 
decrease of the contraction force was also calculated. 
Statistics 
     Statistical comparison of the treated versus non-treated (control) groups was 
conducted by using Student’s t-test (GraphPad Prism v6.0, La Jolla, CA). Differences 
among groups were considered statistically significant when the P value was <0.05. 
Results 
KCl depolarisation 
     KCl caused contraction of the guinea pig tracheal preparation in a concentration 
dependent fashion. The contraction force generated by 20 mM, 30 mM and 50 mM 
was 4.0 ± 2.2, 9.5 ± 2.5 and 13.9 ± 3.1 mN (n=122), respectively. The KCl responses 
were reproducible in control preparations each time they were repeated for 
constructing drug dose-response curves (data not shown). L-VOCC blockers e.g. 
nifedipine and diltiazem decreased the KCl-induced contractions in a concentration 
dependent manner. 10-5 M nifedipine or diltiazem practically abolished the KCl-
induced contractions (Figure 2A,B,C) proving that the applied experimental protocol 
was suitable to test the functional consequences of L-VOCC blockade. The two 
isoquinoline derivatives also decreased KCl-induced contractions in a concentration 
dependent fashion (Figure 2A,B,C), supporting the proposed functional L-VOCC 
blocking activity of both drotaverine and papaverine. However, the potency and 
This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on October 13, 2016 as DOI: 10.1124/jpet.116.237271
 at A
SPET Journals on January 9, 2017
jpet.aspetjournals.org
D
ow
nloaded from
 
JPET#237271 
 
11 
 
efficacy of both drotaverine and papaverine were weaker than that of the reference  
L-VOCC blockers (Figure 2, Table 1). Unlike the L-VOCC blockers, the PDE inhibitor 
theophylline did not modify the KCl-induced contractions indicating that the 
cAMP/PDE system doesn’t play a significant role. The mixture of the equimolar 
concentrations of nifedipine and theophylline behaved more like an L-VOCC blockers 
alone in this experimental mode (Figure 2, Table 1). Interestingly, the inhibitory 
efficacy of the nifedipine and theophylline combination was significantly higher than 
that of nifedipine alone. This observation will be explored in future studies.  
Ca2+ reload followed agonist-induced contractions in Ca2+ free medium (resting 
refill) 
     Both 3x10-6 M histamine and 5x10-7 M methacholine in normal KH solution 
induced tracheal smooth muscle contractions of similar strength (11.9 ± 3.2 mN n=43 
and 10.4 ± 2.8 mN n=32, respectively). With consecutive administration of  histamine 
and methacholine, the contraction force decreased gradually in calcium free KH 
medium to 70.7 ± 14.8%, 22.9 ± 25.1% and 3.0 ± 6.3% (n=43) and 76.2 ± 12.4%, 
13.3 ± 16.8% and 0.4 ± 1.1% (n=32), respectively of the original reference 
contraction (Table 2A and 2B). Following agonist-provoked calcium depletion the 
preparations were put into normal KH solution (reload solution) and incubated for 30 
min in order to let the depleted calcium stores refill (resting refill). The organ bath 
solution was replaced with a calcium free medium (post-reload), after which the 
preparations were able to contract again with agonist stimulation, indicating refilling of 
their intracellular calcium stores (Table 2A and Table 2B, 6th contraction column). L-
VOCC blockers like nifedipine (Figure 3C,4C), or diltiazem (Figure 3D,4D) added to 
the calcium reload medium were able to reduce the agonist-induced contractions (6th 
contraction) in the post-reload Ca2+ free medium. This observation indicates that both 
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L-VOCC blockers may inhibit the resting Ca2+ refill of emptied intracellular calcium 
stores regardless of the constrictor mediator used (Table 2).   
     The non-specific phosphodiesterase inhibitor theophylline was also tested on the 
resting calcium refill model. However, as can be seen in Figure 4E, theophylline, 
unlike L-VOCC blockers enhanced, rather than inhibited the histamine-induced 
contraction. The combination of 10-5 M theophylline with 10-5 M nifedipine in the Ca2+ 
refill medium inhibited the agonist-induced contraction in the post-reload calcium free 
medium (Figure 3F and Figure 4F). 
     Drotaverine and papaverine were also tested on this model (Figure 3A, 4A and 
Figure 3B, 4B). Both drotaverine and papaverine blocked the resting Ca2+refill 
associated contractions at 10-5 M concentration, making these two isoquinoline 
derivatives more similar to the L-VOCC blockers than to the PDE inhibitors. 
CaCl2-induced contraction in agonist containing Ca2+ free medium (receptor 
operated refill) 
     Administration of 2.75 mM CaCl2 to the calcium depleted tracheal preparation 
incubated with histamine (3x10-6M) or methacholine (5x10-7M) in Ca2+ free (0.25 mM 
EGTA) buffer induced a contraction as strong as that produced by the same 
concentration of agonists in normal (2.5 mM Ca2+) KH solution at the start of the 
experimental protocol. Neither the maximal contraction force, nor the slope (Table 3) 
of the contraction of the control preparations differed markedly between the two 
experimental conditions. So the mechanical response to the agonist-induced 
contraction in normal KH solution is identical with the contraction developed by 
adding CaCl2 to the Ca2+ free KH solution containing the agonist.  
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    The L-VOCC blockers, nifedipine or diltiazem (10-5 M), decreased the slope of the 
CaCl2-induced contraction force. This effect was not agonist specific (Table 3), as 
they blunted the force development slope in the presence of both histamine and 
methacholine. 
     In the same model, both drotaverine and papaverine decreased the slope of the 
CaCl2-induced contraction (Table 4), and in this context the two tested isoquinoline 
derivatives behaved like the L-VOCC blockers. However, the PDE inhibitor 
theophylline had no effect on the contraction slope with either agonist in the organ 
bath. The combination of theophylline with nifedipine produced the same result as 
nifedipine alone. There were a variety of potencies among the test compounds with 
respect  to maximum contraction. The rank order for decreasing the contraction 
amplitude in the presence of histamine was; 
diltiazem<theophylline<drotaverine=nifedipine=nifedipine+theophyilline<papaverine, 
while in the presence of methacholine the rank order was; 
theophylline=drotaverine<nifedipine=nifedipine+theophylline<diltiazem<papaverine 
(Figure 5A,B). Based on these results it has been suggested that in the case of 
diltiazem sufficient Ca2+ penetrated the cells to develop contractions as strong as 
histamine or methacholine-induced contractions in normal KH solution. This did not 
appear to be the case with other test molecules because as well as decreasing the 
contraction slope, they modified the maximum CaCl2 –induced contraction force as 
well. Theophylline alone had no effect on either slope or contaction maximum, and 
the nifedipine and theophylline combination acted like nifedipine alone. 
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Discussion 
     Phosphodiesterdase inhibitors have long been used in the treatment. Methylxanthines ( 
e.g. theophylline) are in the frontline for treatment of asthma, while isoquinolines (e.g. 
papaverine) ameliorate the symptoms of visceral smooth muscle spasm and 
associated pain. The medical use of these structurally disimilar PDE inhibitors is 
based on bedside experience rather than on a rational knowledge of their molecular 
mechanism of action.The question to be considered is what molecular mechanisms 
support the different clinical uses for thesetwo types of PDE inhibitor? Based on 
indirect experimental evidence the difference may be associated with their differing 
activity on the voltage operated calcium channel (L-VOCC). 
 It was published that drotaverine increases intracellular cAMP levels by the inhibition 
of PDEs and it may also have an allosteric L-VOCC regulating effect, as proved by 
the displacement of [H3]-nitrendipine (Tömösközi et al., 2002) from its binding site on 
pregnant rat uterine membranes. Two other isoquinoline derivatives, papaverine and 
ethaverine also inhibit PDEs and bind to the L-VOCC (Wang and Rosenberg, 1991; 
Iguchi et al., 1992) suggesting a common cellular mechanism of action for these 
structurally similar derivatives. However, neither the interaction of drotaverine with 
the L-VOCC binding site(s) of guinea pig airway smooth muscle, nor the functional L-
VOCC blocking effect of drotaverine has been investigated to date. Therefore, our 
aim was to provide functional data supporting the L-VOCC blocking effect of 
isoquinoline derivatives using proven L-VOCC dependent tracheal models like the 
KCl depolarisation induced contraction model, the resting Ca2+-refill linked 
contraction model, and the receptor activation associated inward Ca2+-induced 
contraction model. 
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    Traditional L-VOCC blockers and papaverine are able to inhibit the KCl-induced 
contraction through the inhibition of depolarisation triggered inward calcium current 
(Cheng and Townley, 1983; Cerrina et al., 1983; Foster et al., 1984; Baersch and 
Frölich, 1995; Ohashi M and Takayanagi, 1983). Our results showed that both 
papaverine and drotaverine but not theophylline inhibited the KCl-induced 
contractions in a dose-dependent fashion. Others (Small et al., 1989) also 
demonstrated the lack of inhibition by theophylline on the amplitude of KCl-induced 
tracheal contractions. A combination of theophylline with nifedipine produced the 
same effect as nifedipine alone indicating that cAMP/PDE related mechanism wasn’t 
related to L-VOCC function on KCl-induced contraction on guinea pig isolated 
tracheal preparations. Despite widespread use of the KCl model for testing L-VOCC 
blockers it is not truly physiological, as it is not the high extracellular concentration of 
KCl that is responsible for membrane depolarization and the subsequent smooth 
muscle contraction. Instead, airway smooth muscle contraction is considered to be 
Ca2+ dependant, either by the release of intracellularly sequestered Ca2+ or by an 
increase in influx of extracellular Ca2+. In airway smooth muscle Ca2+ release from 
intracellular stores favors inward Ca2+ flux through L-VOCCs following receptor 
activation-induced airway smooth muscle contraction. This mechanism is indirectly 
supported by the relative ineffectiveness of L-VOCC blockers on agonist-induced 
tracheal contractions described by others (Drazen et al., 1983; Advenier et al., 1984; 
Ahmed et al., 1985; Baersch and Frölich, 1995). Repeated agonist stimulation in the 
presence of  L-VOCC blockers results in gradual but only moderately decreasing 
maximal contraction force (Flores-Soto et al., 2013). This indicates that the airway 
smooth muscle is able to contract in a condition when the inward Ca2+ current via L-
VOCCs is blocked. So the intracellular Ca2+ stores are the primary Ca2+ sources for 
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contractions (Creese and Denborough, 1981) and the partly emptied sarcoplasmic 
Ca2+ stores are able to be replenished before a new contraction even if the L-VOCCs 
are blocked. In this case the receptor operated and other calcium channels are 
responsible for the inward Ca2+ current (McFadzean and Gibson, 2002). Contrary to 
the results obtained in normal KH solution, consecutive constrictor mediator 
stimulation in a Ca2+ free medium resulted in gradually decreasing contractions 
(Creese and Denborough, 1981; Noguera et al., 1994). If the  Ca2+ depleted 
preparation is then transferred to a normal Ca2+ containing buffer, the intracellular 
Ca2+ stores are refilled (Noguera et al., 1995). It is highly probable that inward Ca2+ 
flux through the L-VOCC is the main mechanism for the post contraction Ca2+ refill 
(Bourreau et al., 1991; Bourreau et al., 1993; Dessy and Godfraind, 1996; Hirota and 
Janssen, 2007; Flores-Soto et al., 2013). This is called resting Ca2+ refill because the 
agonist is not present between two stimulations when the Ca2+ refill takes place. In 
our studies, repeated histamine or methacholine administration in a Ca2+ free 
medium elicited gradually decreasing contractions indicating the possible depletion of 
the internal Ca2+ stores. Changing the Ca2+ free medium to a normal 2.5 mM Ca2+ 
containing KH buffer (reload medium), the agonists were again able to evoke 
contraction in the post-reload Ca2+ free medium. The observed reaction was mediator 
independent since both the mast cell mediator histamine, and the muscarinic M3 
receptor agonist methacholine, produced the same result. Similarly to the L-VOCC 
blockers (e.g.nifedipine or diltiazem), isoquinolines introduced to the Ca2+ reload 
medium inhibited the histamine or methacholine-induced contraction in the post 
reload Ca2+ free solution suggesting that the observed mechanism is linked to L-
VOCC function. In contrast, using the PDE inhibitor theophylline in the Ca2+ reload 
medium, did not block, and rather increased the magnitude of the constrictor 
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mediator induced contraction. These observations suggest that the Ca2+ refill model 
is L-VOCC dependent, and not inhibited by blocking the cAMP/PDE system.  
     Receptor activation induces the depolarisation of airway smooth muscle resulting 
in inward Ca2+ flux via opening of  both ROCCs and L-VOCCs (Cuthbert et al., 1994; 
Flores-Soto et al., 2013) with subsequent  smooth muscle contraction. Airway smooth 
muscle can replenish the intracellular Ca2+ stores through both ROCCs and L-
VOCCs. The Ca2+ depleted tracheal preparation in an agonist containing Ca2+ free 
medium responded with as strong a contraction by the addition of CaCl2 to the organ 
bath, as the same dose of agonist in normal KH solution. There was also no 
difference in the development speed of the contraction (slope) indicating that with the 
added CaCl2, Ca2+ penetrates rapidly into the Ca2+ depleted smooth muscle and 
evokes a contraction in the presence of either histamine or methacholine. The 
receptor activated refill process was significantly decreased by L-VOCC blockers or 
isoquinoline derivatives (e.g. drotaverine or papaverine) as shown by the reduced 
slope of the CaCl2 contraction curve, but they only moderately affected the amplitude 
of the contraction..  This indicates that the speed of the Ca2+ entry is reduced after L-
VOCC blockade but after a while sufficient Ca2+ becomes accessible to the 
contractile apparatus to allow maximal contraction. So, unlike the resting Ca2+ refill 
model, the L-VOCCs are not the only channel type where the Ca2+ entry into the 
smooth muscle takes place. It seems that L-VOCCs are responsible for rapid Ca2+ 
entry, and other channels allow a slower entry. The PDE inhibitor, theophylline, had 
no effect on either the contraction slope or on the magnitude of contraction, indicating 
that the mechanism is independent of the cAMP/PDE system. This hypothesis is 
further supported by the result that mixed equimolar concentrations of nifedipine and 
theophylline behaved more like L-VOCC blockers. 
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 In conclusion, the experiments we have performed demonstrate a mechanistic 
rationale why the 2 classes of PDE inhibitor successfully treat separate clinical 
indications, but are not interchangeable. 
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Legends for Figures 
Figure 1A. The experimental design for demonstrating the effect of test molecules on 
KCl depolarization-induced contractions. Consecutive 20, 30 and 50 mM KCl-induced 
contractions were evoked twice in normal Krebs-Henseleit solution (KH). The value of 
the second contraction at each KCl concentration was taken as 100%. This was 
followed by three cumulative KCl concentration-response curves, in the presence of 
increasing concentration of the test molecule (or vehicle) with a wash out between 
each. Please note that this is an illustration of the method, not a real trace. W-wash 
out. 
Figure 1B. The experimental design for investigating the intracellular Ca2+ store 
depletion associated decrease in contraction, and subsequent calcium reload 
dependent contraction recovery. Agonist-induced contractions were evoked twice in 
normal Krebs-Henseleit solution (KH), followed by three consecutive agonist 
stimulations (separated by a wash out) in Ca2+ free KH medium. After the third 
stimulation and wash out,  the medium is changed to normal KH solution containing 
the test molecule. After a 30 min incubation,  the medium was again changed to Ca2+ 
free KH solution and three agonist-induced contractions were evoked ieach 
separated by a wash out. Please note that this is an illustration of method, not a real 
trace. C1-control contraction, C2-contraction after test molecule; W-wash out. 
Figure 1C. Experimental protocol for investigating the effect of test molecules on 
CaCl2-induced contraction. Agonist-induced contractions are evoked twice in normal 
Krebs-Henseleit solution (KH) , followed by three consecutive agonist stimulations, 
each separated by a wash out  in Ca2+ free KH medium. After the final wash out, the 
medium was changed to Ca2+ free KH buffer containing the agonistand 2.75 mM 
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CaCl2 was added to the buffer in order to evoke the Ca2+ infux associated 
contraction. Please note that this is an illustration of method, not a real trace. C1-
contraction without test molecule C2-contraction after test molecule, W-wash out. 
Figure 2. The effect of test molecules on KCl induced tracheal contractions. (20 mM 
Figure 2A, 30 mM Figure 2B, 50 mM Figure 2C). The experiments were carried out in 
normal Krebs-Henseleit solution supplemented with the appropriate concentration of 
KCl. Values were expressed as mean ± SD (n =4-8). Student’s t-test was used to 
compare the test molecule treated organs to the vehicle treated control ones. * P< 
0.05  **P< 0.01 or ***P<0.001. 
Figure 3. Histamine-induced guinea pig isolated tracheal contractions in normal and 
calcium free Krebs-Henseleit (KH) solution before and after 30 min incubation in 
normal KH solution (Ca2+ reload) with or without 10-5 M Drotaverine (A), Papaverine 
(B), Nifedipine (C), Diltiazem (D), Theophylline (E) or Theophylline+Nifedipine (F). 
Values represent mean ± SD (n=4-12 preparations). Student’s t-test was used for the 
comparison of control and test molecule treated groups.  *P<0.05, **P<0.01 
***P<0.001. 
Figure 4. Methacholine-induced guinea pig isolated tracheal contractions in normal 
and calcium free Krebs-Henseleit (KH) solution before and after 30 min incubation in 
normal KH solution (Ca reload) with or without 10-5 M Drotaverine (A), Papaverine 
(B), Nifedipine (C), Diltiazem (D) or Theophylline (E) or Theophylline+Nifedipine (F). 
Values represent mean ± SD (n=4-12 preparations). Student’s t-test was used for the 
comparison of control and test molecule treated groups.  *P<0.05, **P<0.01 
***P<0.001. 
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Figure 5. The maximum CaCl2-induced contraction force of intracellular calcium pre-
depleted tracheal preparations in 3x10-6 M histamine (Figure 5A) or 5x10-7 M 
methacholine (Figure 5B) containing Ca2+ free KH solution. The percentage change 
of the contraction force is also indicated on the figures. Values represent the mean ± 
SD (n=4-8) Student’s t-test was used to compare the CaCl2 induced contraction in 
non-treated to the treated organs.  *P<0.05, **P<0.01 ***P<0.001. 
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Tables 
 
 
 
 
 
 
 
 
TABLE 1  
EC50 (μM) values of the test molecules 
The EC50 values of the test compounds calculated at 20, 30 and 50 mM KCl induced tracheal 
contractions. 
Compound 20 mM KCl 30 mM KCl 50 mM KCl 
Drotaverine 9.2 >10 >10 
Papaverine 0.6 5.8 >10 
Nifedipine 0.6 0.6 0.7 
Diltiazem 0.8 4.4 5.7 
Theophyline > 10 > 10 > 10 
Theophyline+ 
Nifedipine 
< 0.1 < 0.1 < 0.1 
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TABLE 2A 
Tracheal smooth muscle contraction in (mN) 
Histamine (3x10-6 M) or methacholine (5x10-7 M)-induced guinea pig isolated tracheal contractions in normal (1st 
contraction and 2nd contraction) and calcium free Krebs-Henseleit (KH) solution before (3rd contraction, 4th 
contraction and 5th contraction) and after incubating for 30 min in normal KH solution (6th contraction and 7th 
contraction). 
 Normal KH solution 
(2.5mM Ca2+) 
Ca2+ free KH solution Ca2+ free KH solution 
Agonist 1st 2nd 3rd 4th 5th 6th 7th 
 
Histamine  
 
10.9 ± 2.8 
 
11.9 ± 3.2 
 
8.6 ± 3.3 
 
2.6 ± 2.5 
 
0.4 ± 0.8 
 
6.5 ± 3.9 
 
0.3 ± 0.9 
 
Methacholine  
 
9.3 ± 2.5 
 
10.4 ± 2.8 
 
8.0 ± 2.7 
 
1.5 ± 2.2 
 
0.4 ± 0.1 
 
4.4 ± 2.6 
 
0.11 ± 0.3 
aValues represent mean ± SD (n=32-43). 
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TABLE 2B   
Tracheal smooth muscle contraction in percentage (mean±SD) 
 Normal KH solution  
(2.5mM Ca2+) 
Ca2+ free KH solution Ca2+ free KH solution 
Agonist 1st 2nd 3rd 4th 5th 6th 7th 
 
Histamine 92.5 ± 8.0 100 70.7 ± 14.8 22.9 ± 25.1 3.0 ± 6.3 52.7 ± 25.4 3.1 ± 10.1 
Methacholine  89.2 ± 5.8 100 76.2 ± 12.4 13.3 ± 16.8 0.4 ± 1.1 42.0 ± 21.1 1.2 ± 2.9 
aValues represent mean ± SD (n=32-43). 
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TABLE 3 
Contraction force (mN) and slope values of different protocols 
Comparison of the contraction force (mN) and slope values of the contractions were obtained 
using four experimental protocols. Histamine (3x10-6 M; Protocol 1), and methacholine (5x10-7 M; 
Protocol 3)-induced tracheal contraction in normal Krebs-Henseleit (KH) solution. CaCl2-induced 
contraction of intracellular calcium pre-depleted tracheal preparations in histamine (Protocol 2) or 
methacholine (Protocol 4) containing Ca2+ free KH solution. 
 Protocol-1 Protocol-2 Protocol-3 Protocol-4 
Contraction force   9.6 ± 2.8 10.2 ± 2.8 11.3 ± 2.5 10.9 ± 2.3 
Slope (x 10-3) 19.9 ± 7.9 12.7 ± 6.0 15.8 ± 5.29 14.5 ± 6.20 
aValues represent the mean ± SD. 
bn=36 (histamine), n=24 (methacholine). 
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TABLE 4 
The slopes of the CaCl2-induced contractions 
The CaCl2-induced contraction slope values for intracellular calcium pre-depleted tracheal 
preparations in histamine (3x10-6 M) or methacholine (5x10-7 M) containing Ca2+ free KH solution.  
 CaCl2 added to histamine 
containing Ca2+ free 
medium (x 10-3) 
p< CaCl2 added to 
methacholine containing 
Ca2+ free medium (x 10-3) 
p< 
control 9.7 ± 3.2  19.6 ± 5.9  
10-5M Drotaverine 1.2 ± 1.1 0.001 3.5 ± 2.5 0.01 
control 19.1 ± 13  11.8 ± 4.6  
10-5M Papaverine 1.1 ± 0.5 0.05 0.8 ± 0.3 0.01 
control 11.4 ± 4.2  10.1 ± 3.3  
10-5M Nifedipine 1.1 ± 0.4 0.001 1.0 ± 0.5 0.01 
control 14.5 ± 5.0  13.7 ± 2.4  
10-5M Diltiazem 2.4 ± 1.1 0.001 0.7 ± 0.3 0.001 
control 10.6  ± 3.6  12.6 ± 6.4  
10-5M Theophylline 13.9  ± 4.1 n.s. 8.4 ± 1.4 n.s. 
Control 13.9 ± 3.3  17.9 ± 9.4  
10-5M Theophylline  
+10-5M Nifedipine 
0.9  ± 0.3 0.001 0.9 ± 0.2 0.05 
aThe slope values represent the mean ± SD (n=4-8).   
bStudent’s t-test was used to compare the non treated to the treated slope values. 
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